Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain”
暂无分享,去创建一个
G. Ricken | E. Gelpí | G. Kovacs | G. Regelsberger | T. Ströbel | O. Kalev | H. Budka | S. Klotz | Nuria Vidal-Robau | M. Leoni | Nuria Vidal-Robau
[1] I. Ferrer,et al. Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease , 2021, Prion.
[2] K. Popovič,et al. A case of MV2K subtype of sporadic Creutzfeldt–Jakob disease with florid‐like plaques: Similarities and differences to variant Creutzfeldt–Jakob disease , 2020, Neuropathology : official journal of the Japanese Society of Neuropathology.
[3] M. C. Angulo,et al. Glutamate versus GABA in neuron–oligodendroglia communication , 2019, Glia.
[4] A. Green,et al. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC , 2019, Journal of Neurology.
[5] J. Fawcett,et al. The roles of perineuronal nets and the perinodal extracellular matrix in neuronal function , 2019, Nature Reviews Neuroscience.
[6] E. Gould,et al. Oligodendrocytes regulate presynaptic properties and neurotransmission through BDNF signaling in the mouse brainstem , 2019, eLife.
[7] I. Vida,et al. Differential Dependence of GABAergic and Glutamatergic Neurons on Glia for the Establishment of Synaptic Transmission , 2019, Cerebral cortex.
[8] A. Giese,et al. Regional pattern of microgliosis in sporadic Creutzfeldt‐Jakob disease in relation to phenotypic variants and disease progression , 2018, Neuropathology and applied neurobiology.
[9] I. Ferrer,et al. Sporadic Creutzfeldt–Jakob disease with glial PrPRes nuclear and perinuclear immunoreactivity , 2018, Neuropathology : official journal of the Japanese Society of Neuropathology.
[10] I. Ferrer,et al. Altered gene transcription linked to astrocytes and oligodendrocytes in frontal cortex in Creutzfeldt-Jakob disease , 2018, Prion.
[11] I. Aiba,et al. An autopsied case of MV2K + C‐type sporadic Creutzfeldt‐Jakob disease presenting with widespread cerebral cortical involvement and Kuru plaques , 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.
[12] Kristina D Micheva,et al. A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons , 2016, eLife.
[13] N. Bargalló,et al. Sporadic MM2‐thalamic + cortical Creutzfeldt‐Jakob disease: Utility of diffusion tensor imaging in the detection of cortical involvement in vivo , 2016, Neuropathology : official journal of the Japanese Society of Neuropathology.
[14] I. Ferrer,et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA , 2012, Acta Neuropathologica.
[15] Pierre J. Magistretti,et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.
[16] S. Cawthraw,et al. Experimental H-type and L-type bovine spongiform encephalopathy in cattle: observation of two clinical syndromes and diagnostic challenges , 2012, BMC Veterinary Research.
[17] M. Simmons,et al. Experimental Classical Bovine Spongiform Encephalopathy , 2011, Veterinary pathology.
[18] J. Ovádi,et al. Tubulin polymerization‐promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation , 2010, Glia.
[19] B. Ghetti,et al. Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.
[20] K. Jellinger,et al. Multiple system atrophy: A primary oligodendrogliopathy , 2008, Annals of neurology.
[21] M. Simmons,et al. Immunohistochemistry for PrPSc in natural scrapie reveals patterns which are associated with the PrP genotype , 2007, Neuropathology and applied neurobiology.
[22] K. Kallenberg,et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. , 2006, Archives of neurology.
[23] M. Simmons,et al. BSE immunohistochemical patterns in the brainstem: a comparison between UK and Italian cases , 2006, Acta Neuropathologica.
[24] H. Budka,et al. Subcellular localization of disease-associated prion protein in the human brain. , 2005, The American journal of pathology.
[25] J. Ironside,et al. Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt–Jakob disease , 2000, Neuropathology and applied neurobiology.
[26] H. Budka,et al. Early Destruction of the Extracellular Matrix around Parvalbumin-Immunoreactive Interneurons in Creutzfeldt-Jakob Disease , 1999, Neurobiology of Disease.
[27] P Brown,et al. Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.
[28] P. Brown,et al. Modifications of Oligodendroglial Cells in Spongiform Encephalopathies , 1998, Experimental Neurology.
[29] P. Liberski,et al. Severe, Early and Selective Loss of a Subpopulation of GABAergic Inhibitory Neurons in Experimental Transmissible Spongiform Encephalopathies , 1998, Brain pathology.
[30] H. Budka,et al. Distribution of Parvalbumin‐Immunoreactive Neurons in Brain Correlates with Hippocampal and Temporal Cortical Pathology in Creutzfeldt‐Jakob Disease , 1997, Journal of neuropathology and experimental neurology.
[31] J. Bell,et al. A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. , 1996, Cold Spring Harbor symposia on quantitative biology.
[32] I. Ferrer,et al. Parvalbumin‐immunoreactive cortical neurons in Creutzfeldt‐Jakob disease , 1993, Annals of neurology.
[33] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.